Journal profile · PHARMACOLOGY & PHARMACY
Current Drug Delivery
ISSN 1567-2018 · eISSN 1875-5704 · Bentham Science Publishers B.V. · U ARAB EMIRATES
Current Drug Delivery: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.04; subscription journal; median 86 days to acceptance (43 articles, last 24 months); 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Drug Delivery is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems and Advancements in Transdermal Drug Delivery, together about 46.1% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves. The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance. The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
Source: LetPub
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics20.8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics13.1%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics12.2%
- Nanoparticle-Based Drug DeliveryMaterials Science11.2%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.5%
- Inhalation and Respiratory Drug DeliveryMedicine2.8%
- Nanoplatforms for cancer theranosticsEngineering2.8%
- Hydrogels: synthesis, properties, applicationsBiochemistry, Genetics and Molecular Biology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.04LetPub ·
- CiteScore 2026-06
- 6.9LetPub ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.57LetPub ·
- h-index
- 54LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 1,058OpenAlex ·
- 2-year mean citedness
- 2.91OpenAlex ·
- Self-citation rate
- 3.2%LetPub ·
- Share of gold OA articles
- 3.66%LetPub ·
Volume
- Articles per year
- 74LetPub ·
Articles by year OpenAlex count · 2,067 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 83 | 3 | 16 |
| 2025 | 61 | 5 | 110 |
| 2024 | 99 | 10 | 580 |
| 2023 | 104 | 5 | 935 |
| 2022 | 163 | 3 | 1,711 |
| 2021 | 169 | 14 | 1,787 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
86 daysMedian, submission to acceptance · P25–P75 64 days – 112 days
- Acceptance to online
- median 204 days (43 articles)
- Submission to online
- median 281 days
- Sample
- 43 articles with submission and acceptance dates (272 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham Science Publishers B.V.
- Country or region
- U ARAB EMIRATES
- Language
- English
- ISSN
- 1567-2018
- Electronic ISSN
- 1875-5704
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Drug Delivery
What CAS zone is Current Drug Delivery in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Drug Delivery is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Drug Delivery?
The latest impact factor listed by LetPub is 3.04; CiteScore 6.9, h-index 83.
How long does peer review take at Current Drug Delivery?
Based on the dates recorded on 43 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 64–112 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Drug Delivery?
According to LetPub and DOAJ records, Current Drug Delivery is indexed in SCIE and Scopus.
Is Current Drug Delivery open access, and what is the APC?
Current Drug Delivery is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .